Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...
Public health experts are concerned about mutated versions of SARS-CoV-2, the virus that causes COVID, that combine the worst elements of different strains. When two or more slightly different ...
In this episode, we discuss recombinant antibodies: what are they and what are they used for? BioTechniques Senior Editor Tristan Free, speaks to Amy Sheng (left), Technical Account Manager at Sino ...
insights from industryDr. Tillman ZiegertManaging DirectorBiorbyt Ltd. In this interview, News-Medical speaks to Dr. Tillmann Ziegert, Managing Director at Biorbyt Ltd., about the balance between ...
Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...
GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been ...
"We've had XA, XB, XC, XD already." A new COVID-19 variant has been identified in the United Kingdom, but experts say there is no cause for alarm yet. The variant, known as XE, is a combination of the ...
A new Covid-19 variant that combines two different omicron strains has been identified in the United Kingdom, and it could be the fastest-spreading Covid variant yet, according to early data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback